GSK Investigational Site

Bad Bramstedt, Schleswig-Holstein 24576

0 studies enrolling now · 5 studies all time

What they study most

Churg-Strauss Syndrome, Eosinophilic Granulomatosis With Polyangiitis, Hypereosinophilia, Hypereosinophilic Syndrome, Influenza

Studies at this site

• Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921 — Completed
• Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES) — Completed
• Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older — Completed
• A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis — Completed
• Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome — Stopped early